ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
오피오이드 시장 규모는 최근 꾸준히 성장하고 있습니다. 2025년 239억 8,000만 달러에서 2026년에는 246억 3,000만 달러에 이르고, CAGR 2.7%의 성장이 전망되고 있습니다. 지난 수년간의 성장에는 수술 후 통증의 유병률, 암 발병률 증가, 오피오이드 처방의 광범위한 보급, 대체 통증 치료법의 제한적인 가용성, 병원에서의 오피오이드 사용 증가 등이 영향을 미친 것으로 추정됩니다.
오피오이드 시장 규모는 향후 몇 년간도 꾸준한 성장이 전망됩니다. 2030년에는 285억 9,000만 달러에 이르고, CAGR은 3.8%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 만성 통증 환자 증가, 안전성 개선형 오피오이드 제제 개발, 완화의료 서비스 확대, 규제 물질에 대한 규제 명확화, 고령화 사회에서의 효과적인 통증 관리에 대한 수요 증가 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 정밀 오피오이드 치료법 개발, 디지털 처방 모니터링 시스템 통합, 오남용 방지 제제로의 전환, 장시간 작용 및 서방형 오피오이드의 확대, 종양학 분야의 통증 관리에서 오피오이드 사용 증가 등을 꼽을 수 있습니다.
향후 몇 년 동안 만성 질환의 유병률 증가가 오피오이드 시장의 성장을 견인할 것으로 예측됩니다. 만성질환(비감염성 질환: NCDs라고도 함)은 일반적으로 진행이 완만하고 장기간 지속되는 장기적인 병태입니다. 이러한 병태는 수년 또는 평생 지속되는 경우가 많으며, 보통 자연 치유되지 않습니다. 만성 질환 증가는 만성 통증을 경험하고 효과적인 통증 관리를 필요로 하는 환자 수가 증가함에 따라 오피오이드 시장을 뒷받침하는 주요 요인입니다. 오피오이드는 만성 질환 관리에서 상당한 통증 완화를 제공하기 위해 사용됩니다. 예를 들어, 2024년 6월 영국 정부 기관인 국민보건서비스(NHS)가 발표한 자료에 따르면, 2023년 일반의(GP)에 등록된 환자 3,615,330명이 비당뇨병성 고혈당 또는 전당뇨병으로 진단을 받았습니다. 이는 2022년 3,065,825건에서 18% 증가한 수치입니다. 따라서 만성질환 유병률 증가는 오피오이드 시장의 성장을 가속하고 있습니다.
오피오이드 시장의 주요 기업들은 시장에서의 입지를 강화하기 위해 첨단 제약 솔루션 개발에 주력하고 있습니다. 혁신적인 의약품의 창출은 의료 수요에 대응하는 데 기여하는 동시에 헬스케어와 과학적 지식의 진보를 촉진합니다. 예를 들어, 2023년 5월 미국 기반의 오피오이드 중독 치료제 공급업체인 브레이번 파마슈티컬스(Braeburn Pharmaceuticals)는 중등도에서 중증의 오피오이드 사용 장애(OUD) 치료를 위한 피하 투여용 서방형 주사제 브릭사디(Bixadi, 성분명: 부프레놀핀)가 미국 식품의약국(FDA)의 승인을 받았다고 발표했습니다. 미국 식품의약국(FDA)의 승인을 받았다고 발표했습니다. 중등도에서 중증의 OUD에 대한 최초의 주 1회,월1회 피하주사제이며, FluidCrystal Injection Depot Technology를 적용한 최초의 부프레노르핀 주사제입니다. 경구용 부프레노르핀을 복용 중인 환자는 처방 지침에 따라 동등한 용량으로 안전하게 전환할 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Opioids are a class of potent medications derived from or synthesized from the opium poppy plant that act on the nervous system to relieve pain. They are highly effective in treating moderate to severe pain, including post-surgical pain, cancer-related pain, and chronic pain conditions, as well as managing coughing and diarrhea.
The main types of opioid products include methadone, codeine, fentanyl, oxycodone, morphine, hydrocodone, and others. Methadone is an opioid used in medication-assisted treatment (MAT) programs to help individuals reduce or stop their use of heroin or other opioids. Opioids act through various receptor bindings, including strong agonists and mild to moderate agonists. They are administered for multiple indications, such as inflammatory conditions, musculoskeletal pain, neuropathic pain, and cancer pain, and are available through hospitals, retail pharmacies, and online pharmacies. These drugs are used in various applications, including pain management, cough treatment, and diarrhea management.
Tariffs have impacted the opioids market by increasing costs associated with active pharmaceutical ingredients, excipients, and cross-border manufacturing of controlled drugs, particularly affecting synthetic opioids such as fentanyl and oxycodone. Supply chain disruptions and higher import duties have strained pharmaceutical manufacturers, especially in regions dependent on API imports such as Asia-Pacific and parts of Europe. Hospital and retail pharmacy segments have experienced pricing pressures and procurement delays due to tariff-induced cost inflation. However, tariffs have also encouraged localized production, contract manufacturing expansion, and investment in domestic API manufacturing, supporting long-term supply resilience and regulatory compliance within key markets.
The opioids market research report is one of a series of new reports from The Business Research Company that provides opioids market statistics, including opioids industry global market size, regional shares, competitors with a opioids market share, detailed opioids market segments, market trends and opportunities, and any further data you may need to thrive in the opioids industry. This opioids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The opioids market size has grown steadily in recent years. It will grow from $23.98 billion in 2025 to $24.63 billion in 2026 at a compound annual growth rate (CAGR) of 2.7%. The growth in the historic period can be attributed to post-surgical pain prevalence, rising cancer incidence, widespread opioid prescription practices, limited availability of alternative pain therapies, strong hospital-based opioid usage.
The opioids market size is expected to see steady growth in the next few years. It will grow to $28.59 billion in 2030 at a compound annual growth rate (CAGR) of 3.8%. The growth in the forecast period can be attributed to growth in chronic pain population, development of safer opioid formulations, expansion of palliative care services, increasing regulatory clarity for controlled substances, rising demand for effective pain management in aging populations. Major trends in the forecast period include precision-guided opioid therapy development, digital prescription monitoring integration, shift toward abuse-deterrent formulations, expansion of long-acting and extended-release opioids, growing use of opioids in oncology pain management.
The rising prevalence of chronic diseases is expected to drive the growth of the opioids market in the coming years. Chronic diseases, also referred to as non-communicable diseases (NCDs), are long-term medical conditions that generally progress slowly and persist over extended periods. These conditions often last for years or even a lifetime and typically do not resolve on their own. The growing prevalence of chronic diseases is a key factor supporting the opioids market, as an increasing number of people experience chronic pain and require effective pain management. Opioids are used in chronic disease management to provide significant pain relief. For instance, in June 2024, the National Health Service, a UK-based government agency, reported that in 2023, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes, reflecting an 18% increase from 3,065,825 cases in 2022. Therefore, the rising prevalence of chronic diseases is propelling the growth of the opioids market.
Major companies in the opioids market are concentrating on developing advanced drug solutions to strengthen their market position. The creation of innovative medications helps address medical needs while advancing healthcare and scientific understanding. For instance, in May 2023, Braeburn Pharmaceuticals Inc., a US-based provider of opioid addiction treatments, announced that the US Food and Drug Administration approved Brixadi (buprenorphine) extended-release injectable for subcutaneous administration for the treatment of moderate to severe opioid use disorder (OUD). It is the first and only weekly and monthly subcutaneous injection for moderate to severe OUD and the first buprenorphine injectable using FluidCrystal Injection Depot Technology. Patients on oral buprenorphine can be safely transitioned to equivalent doses following prescribing guidelines.
In March 2023, Indivior PLC, a US-based specialty pharmaceutical company, acquired Opiant Pharmaceuticals Inc. for $145 million. This acquisition provides Indivior with a comprehensive treatment platform to address the ongoing opioid crisis in the United States. It also strengthens Indivior's addiction treatment and scientific portfolio by integrating Opiant's late-stage assets, particularly OPNT003. Opiant Pharmaceuticals Inc. is a US-based developer of therapies for opioid overdose and addiction management.
Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca Plc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals plc, Alkermes plc, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.
North America was the largest region in the opioids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the opioids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the opioids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The opioids market consists of sales of oxycodone (OxyContin), hydrocodone (Vicodin), morphine and methadone. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Opioids Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses opioids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for opioids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The opioids market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Product Type: Methadone; Codeine; Fentanyl; Oxycodone; Morphine; Hydrocodone; Other Product Types
2) By Receptor Binding: Strong Agonist; Mild To Moderate Agonist
3) By Basis Of Indication: Inflammatory Condition; Musculoskeletal Pain; Neuropathic Pain; Cancer Pain
4) By Distribution Channel: Hospital; Retail Pharmacies; Online Pharmacies
5) By Application: Pain Management; Cough Treatment; Diarrhea Treatment
Subsegments:
1) By Methadone: Methadone Tablets; Methadone Oral Solution
2) By Codeine: Codeine Phosphate Tablets; Codeine Liquid Formulations
3) By Fentanyl: Fentanyl Patch; Fentanyl Injection; Fentanyl Sublingual Tablets
4) By Oxycodone: Oxycodone Tablets; Oxycodone Extended-Release Formulations
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Precision-Guided Opioid Therapy Development
4.2.2 Digital Prescription Monitoring Integration
4.2.3 Shift Toward Abuse-Deterrent Formulations
4.2.4 Expansion Of Long-Acting And Extended-Release Opioids
4.2.5 Growing Use Of Opioids In Oncology Pain Management
5. Opioids Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Pain Management Clinics
5.3 Oncology Centers
5.4 Rehabilitation Centers
5.5 Home Healthcare Providers
6. Opioids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Opioids Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Opioids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Opioids Market Size, Comparisons And Growth Rate Analysis
7.3. Global Opioids Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Opioids Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Opioids Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Opioids Market Segmentation
9.1. Global Opioids Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types
9.2. Global Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Strong Agonist, Mild To Moderate Agonist
9.3. Global Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain
9.4. Global Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospital, Retail Pharmacies, Online Pharmacies
9.5. Global Opioids Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.12. Global Opioids Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Buprenorphine, Tramadol, Other Combination Products
10. Opioids Market Regional And Country Analysis
10.1. Global Opioids Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Opioids Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Opioids Market
11.1. Asia-Pacific Opioids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Opioids Market
12.1. China Opioids Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Opioids Market
13.1. India Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Opioids Market
14.1. Japan Opioids Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Opioids Market
15.1. Australia Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Opioids Market
16.1. Indonesia Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Opioids Market
17.1. South Korea Opioids Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Opioids Market
18.1. Taiwan Opioids Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Opioids Market
19.1. South East Asia Opioids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Opioids Market
20.1. Western Europe Opioids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Opioids Market
21.1. UK Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Opioids Market
22.1. Germany Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Opioids Market
23.1. France Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Opioids Market
24.1. Italy Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Opioids Market
25.1. Spain Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Opioids Market
26.1. Eastern Europe Opioids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Opioids Market
27.1. Russia Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Opioids Market
28.1. North America Opioids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Opioids Market
29.1. USA Opioids Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Opioids Market
30.1. Canada Opioids Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Opioids Market
31.1. South America Opioids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Opioids Market
32.1. Brazil Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Opioids Market
33.1. Middle East Opioids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Opioids Market
34.1. Africa Opioids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Opioids Market Regulatory and Investment Landscape
36. Opioids Market Competitive Landscape And Company Profiles
36.1. Opioids Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Opioids Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Opioids Market Company Profiles
36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Johnson & Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Sanofi S.A Overview, Products and Services, Strategy and Financial Analysis
36.3.5. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
37. Opioids Market Other Major And Innovative Companies
Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals plc, Alkermes plc, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd.
38. Global Opioids Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Opioids Market
40. Opioids Market High Potential Countries, Segments and Strategies
40.1 Opioids Market In 2030 - Countries Offering Most New Opportunities
40.2 Opioids Market In 2030 - Segments Offering Most New Opportunities
